颅内接种肿瘤细胞裂解物联合鞭毛蛋白对小鼠胶质瘤的治疗效果
研究在小鼠GL261胶质瘤模型中测试鞭毛蛋白联合肿瘤细胞裂解物(TCL)的免疫治疗效果。预防性皮下接种可诱导细胞毒性T淋巴细胞并延长生存,治疗性皮下接种无效,但治疗性颅内接种可延长生存。颅内鞭毛蛋白可招募CD4+和CD8+ T细胞至脑组织并诱导外周血单个核细胞中NK细胞及T细胞增殖。
要点
- 预防性皮下接种TCL加鞭毛蛋白可诱导CTL并显著延长GL261荷瘤小鼠生存。
- 治疗性皮下接种TCL加鞭毛蛋白未能延长生存。
- 治疗性颅内接种TCL加鞭毛蛋白可延长荷瘤小鼠生存。
核心结论
- 鞭毛蛋白可作为TCL疫苗的有效佐剂,颅内治疗性接种TCL加鞭毛蛋白可延长小鼠胶质瘤生存。
研究设计与样本
- 将GL261细胞移植入C57BL/6小鼠,荷瘤鼠分别皮下或颅内接种鞭毛蛋白加TCL、鞭毛蛋白、TCL或生理盐水。
主要发现
- 预防性皮下接种TCL加鞭毛蛋白可诱导强效细胞毒性T淋巴细胞并显著延长GL261荷瘤小鼠生存。
- 治疗性皮下接种TCL加鞭毛蛋白未能延长生存。
- 治疗性颅内接种TCL加鞭毛蛋白可延长生存。
- 颅内接种鞭毛蛋白可招募CD4+ T细胞和CD8+ T细胞至脑组织,诱导外周血单个核细胞中NK细胞、CD4+ T细胞和CD8+ T细胞增殖,并诱导脾肿大。
临床怎么用
- 提示鞭毛蛋白作为TCL疫苗佐剂时,接种途径(颅内 vs 皮下)和时机(预防 vs 治疗)影响胶质瘤免疫治疗效果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The adjuvant effects of flagellin on regulation of immune response have been proved; whether flagellin could assist tumor cell lysate (TCL) to enhance anti-glioma immunity remains to be investigated. This study tests a hypothesis that therapeuticly intracranial administration with flagellin plus TCL enhances the effects of specific immunotherapy on glioma in mice. In this study, GL261 cells were transferred into C57BL/6 mice and the GL261-bearing mice were subcutaneously or intracranially inoculated with flagellin plus TCL, flagellin, TCL or saline. Our results showed that prophylacticly subcutaneous administration with TCL and flagellin could induce potent cytotoxic T lymphocyte (CTL) and prolong the survival of GL261-bearing mice significantly, but therapeuticly subcutaneous administration failed to. However, therapeuticly intracranial administration of TCL plus flagellin could prolong the survival. Moreover, intracranial administration of flagellin could recruit CD4+ T cells and CD8+ T cells to brain tissues, induce proliferation of natural killer (NK) cells, CD4+ T cells and CD8+ T cells in peripheral blood mononuclear cells and induce to splenomegaly. The results suggested that flagellin could be acted as an efficient adjuvant for TCL based vaccine.
引用
- Dong B, Wang L, Nie S, et al. Anti-glioma effect of intracranial vaccination with tumor cell lysate plus flagellin in mice. Vaccine. 2018. PMID: 30449633. doi:10.1016/j.vaccine.2018.04.053
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。